Patents by Inventor Markus Daniel Lacher

Markus Daniel Lacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277640
    Abstract: The present invention provides a modified human cancer cell comprising a recombinant polynucleotide encoding an allele of a human leukocyte antigen gene. The present invention also provides methods for selecting a whole-cell cancer vaccine for a subject having cancer and methods of treating cancer using whole-cell cancer vaccines of the present invention. In addition, the present invention provides a method of determining the HER2 status of a cell. Compositions and kits are also provided herein.
    Type: Application
    Filed: December 9, 2022
    Publication date: September 7, 2023
    Applicant: BriaCell Therapeutics Corp.
    Inventors: Markus Daniel Lacher, Joseph Paul Wagner, Charles Louis Wiseman, William Valentine Williams
  • Patent number: 11559574
    Abstract: The present invention provides a modified human cancer cell comprising a recombinant polynucleotide encoding an allele of a human leukocyte antigen gene. The present invention also provides methods for selecting a whole-cell cancer vaccine for a subject having cancer and methods of treating cancer using whole-cell cancer vaccines of the present invention. In addition, the present invention provides a method of determining the HER2 status of a cell. Compositions and kits are also provided herein.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 24, 2023
    Assignee: BriaCell Therapeutics Corp.
    Inventors: Markus Daniel Lacher, Joseph Paul Wagner, Charles Louis Wiseman, William Valentine Williams
  • Publication number: 20190046624
    Abstract: The present invention provides a modified human cancer cell comprising a recombinant polynucleotide encoding an allele of a human leukocyte antigen gene. The present invention also provides methods for selecting a whole-cell cancer vaccine for a subject having cancer and methods of treating cancer using whole-cell cancer vaccines of the present invention. In addition, the present invention provides a method of determining the HER2 status of a cell. Compositions and kits are also provided herein.
    Type: Application
    Filed: August 23, 2018
    Publication date: February 14, 2019
    Applicant: BriaCell Therapeutics Corp.
    Inventors: Markus Daniel Lacher, Joseph Paul Wagner, Charles Louis Wiseman, William Valentine Williams
  • Publication number: 20140357518
    Abstract: The invention provides methods, compositions and kits for the detection and treatment of thyroid cancer.
    Type: Application
    Filed: January 11, 2013
    Publication date: December 4, 2014
    Applicant: Oncocyte Corporation
    Inventors: Karen Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd
  • Publication number: 20140323342
    Abstract: The invention provides methods, compositions and kits for the detection and treatment of bladder cancer.
    Type: Application
    Filed: November 15, 2012
    Publication date: October 30, 2014
    Inventors: Karen Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorrie Kidd, Maria J. Prendes
  • Publication number: 20140221244
    Abstract: The invention provides methods, compositions and kits relating to the detection, diagnosis, treatment of colorectal cancer.
    Type: Application
    Filed: August 31, 2012
    Publication date: August 7, 2014
    Inventors: Karen Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd, Maria Prendes
  • Publication number: 20140206574
    Abstract: The invention relates to methods of detecting cancer in a sample obtained from a subject. The invention also provides kits and reagents for detecting cancer as well as therapeutics and methods of treating cancer.
    Type: Application
    Filed: August 31, 2012
    Publication date: July 24, 2014
    Inventors: Karen Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd, Maria J. Prendes
  • Publication number: 20140154691
    Abstract: Embodiments of the disclosure are directed to methods of diagnosis, prognosis and treatment of cancer. The methods are particularly suited for bladder cancer. The methods include targeting a marker that is expressed at abnormal levels in bladder cancer tissue in comparison to normal somatic tissue. Also disclosed are methods of treating cancer comprising administering a composition including a therapeutic that affects the expression or function of a target marker.
    Type: Application
    Filed: June 22, 2012
    Publication date: June 5, 2014
    Applicant: ONCOCYTE CORPORATION
    Inventors: Karen Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd
  • Publication number: 20140141996
    Abstract: Embodiments of the disclosure are directed to methods of diagnosis, prognosis and treatment of cancer. In some embodiments, the methods include targeting a marker that is expressed at abnormal levels in bladder cancer tissue in comparison to normal somatic tissue. Some embodiments are directed to methods of treating cancer comprising administering a composition including a therapeutic that affects the expression or function of a target marker.
    Type: Application
    Filed: June 23, 2012
    Publication date: May 22, 2014
    Applicant: ONCOCYTE CORPORATION
    Inventors: Karen Chapman, Joseph Wagner, Michael West, Markus Daniel Lacher, Jennifer Lorie Kidd, Maria Prendes